Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Argyria is a rare dermatosis, which can be either localized or systemic, that occurs after prolonged contact and absorption of silver containing compounds over a period of years and that is characterized by irreversible blue-gray to gray-black staining of skin, fingernails and/or mucous membranes, most evident on sun exposed areas of the skin. Silver exposure is usually occupational but may also occur through dental amalgams, the ingestion of colloidal silver, acupuncture needles, orthopedic implants and topical medications (such as silver sulfadiazine).
Biomarker and diagnostic research for argyria has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for argyria.
145 publications have been identified in PubMed for argyria. Research spans Basic Science / Preclinical (63%), Case Report / Case Series (16%), and Diagnostic / Biomarker (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 91 | 63% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:11 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
23 |
16% |
Testing and diagnosis research | 11 | 8% |
Research summaries | 6 | 4% |
Disease patterns and progression | 6 | 4% |
Clinical study results | 3 | 2% |
New treatment approaches | 3 | 2% |
Other research | 2 | 1% |
Yang X (2026). [PMID: 41486276](https://pubmed.ncbi.nlm.nih.gov/41486276/). *Scientific reports*. [Basic Science / Preclinical]
Li C (2026). [PMID: 41245814](https://pubmed.ncbi.nlm.nih.gov/41245814/). *Non-coding RNA research*. [Basic Science / Preclinical]
Espinosa ALF (2026). [PMID: 41269905](https://pubmed.ncbi.nlm.nih.gov/41269905/). *Acta Cytol*. [Diagnostic / Biomarker]
Oshima K (2026). [PMID: 41503450](https://pubmed.ncbi.nlm.nih.gov/41503450/). *IDCases*. [Case Report / Case Series]
Li M (2026). [PMID: 41816487](https://pubmed.ncbi.nlm.nih.gov/41816487/). *J Thorac Dis*. [Diagnostic / Biomarker]
Ma W (2026). [PMID: 41872444](https://pubmed.ncbi.nlm.nih.gov/41872444/). *Mediators of inflammation*. [Basic Science / Preclinical]
Limmer EE (2026). [PMID: 41559016](https://pubmed.ncbi.nlm.nih.gov/41559016/). *International journal of dermatology*. [Case Report / Case Series]
de Arruda JAA (2026). [PMID: 41991326](https://pubmed.ncbi.nlm.nih.gov/41991326/). *J Cutan Pathol*. [Case Report / Case Series]
Ma S (2026). [PMID: 41347581](https://pubmed.ncbi.nlm.nih.gov/41347581/). *Analytical methods : advancing methods and applications*. [Basic Science / Preclinical]
Alhamoud A (2026). [PMID: 41332972](https://pubmed.ncbi.nlm.nih.gov/41332972/). *Radiol Case Rep*. [Case Report / Case Series]